{"id":17538,"date":"2016-04-21T00:00:00","date_gmt":"2016-04-21T00:00:00","guid":{"rendered":"https:\/\/cadca1stg.wpengine.com\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/"},"modified":"2016-04-21T00:00:00","modified_gmt":"2016-04-21T00:00:00","slug":"critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee","status":"publish","type":"resource","link":"https:\/\/www.cadca.org\/es\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/","title":{"rendered":"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee"},"content":{"rendered":"<p>Ayer, el Subcomit\u00e9 de Salud de Energ\u00eda y Comercio de la C\u00e1mara de Representantes aprob\u00f3 por unanimidad 12 iniciativas legislativas bipartidistas destinadas a abordar los problemas de abuso de drogas y opioides que afectan a las comunidades de todo el pa\u00eds.<\/p>\n<p>HR 3250, Ley de Prevenci\u00f3n del Abuso de DXM, escrita por el Representante Bill Johnson (R-Ohio) y la Representante Doris Matsui (D-Calif.) es una de esas leyes. El proyecto de ley, respaldado durante mucho tiempo por CADCA, restringir\u00eda la venta de productos que contengan dextrometorfano (DXM) a adultos mayores de 18 a\u00f1os en todo el pa\u00eds e impondr\u00eda restricciones a la distribuci\u00f3n de DXM a granel.<\/p>\n<p>Al igual que otros medicamentos recetados y de venta libre, cuando se usa correctamente, DXM es completamente seguro. Sin embargo, en los \u00faltimos a\u00f1os, un subconjunto de adolescentes ha estado abusando de esta droga. Cuando se ingiere en dosis altas, los efectos secundarios pueden incluir confusi\u00f3n, mareos, visi\u00f3n doble o borrosa, dificultad para hablar, p\u00e9rdida de coordinaci\u00f3n f\u00edsica, v\u00f3mitos, taquicardia y, en algunos casos, muertes no deseadas.<\/p>\n<p>Las restricciones de edad proporcionan una forma eficaz de limitar el acceso a la peque\u00f1a poblaci\u00f3n de adolescentes que probablemente abusa de los medicamentos para la tos. CADCA y sus 5.000 miembros en todo el pa\u00eds elogian los esfuerzos del subcomit\u00e9 para proteger a nuestra juventud y hacer avanzar esta importante legislaci\u00f3n.<\/p>\n<p>CADCA tambi\u00e9n apoya la aprobaci\u00f3n por parte del subcomit\u00e9 de las siguientes leyes:<\/p>\n<ul>\n<li>La Ley de Ampliaci\u00f3n y Modernizaci\u00f3n del Tratamiento de Trastornos por Uso de Opioides, redactada por el representante Larry Bucshon, MD (R-Ind.) y el representante Paul Tonko (D-NY), que toma medidas importantes para ampliar el acceso al tratamiento asistido con medicamentos y minimizar el potencial para el desv\u00edo de drogas.<br \/>\n\t\u00a0<\/li>\n<li>HR 4586, Ley Lali, escrita por el representante Bob Dold (R-Ill.) y la representante Katherine Clark (D-Mass.), que autoriza subvenciones para que los estados desarrollen \u00f3rdenes permanentes para las recetas de naloxona y al mismo tiempo capaciten a los profesionales de la salud sobre la dispensaci\u00f3n de Medicamentos para revertir una sobredosis de opioides.<\/li>\n<\/ul>\n<p>Todos estos esfuerzos son fundamentales para mantener comunidades seguras, saludables y libres de drogas. En un momento en que nuestro pa\u00eds se enfrenta a una devastadora epidemia de opioides y hero\u00edna, debemos promulgar soluciones concretas para el futuro. En 2014, los CDC informaron m\u00e1s de 47.000 muertes por sobredosis, m\u00e1s de 14.000 de ellas por medicamentos recetados y m\u00e1s de 10.500 por hero\u00edna. Ahora, m\u00e1s que nunca, necesitamos promulgar estas propuestas. CADCA agradece al subcomit\u00e9 por tomar medidas en estos temas.<\/p>\n<p><strong>VER TAMBI\u00c9N:<\/strong><\/p>\n<p><a href=\"https:\/\/www.cadca.org\/es\/resources\/coalitions-action-pennsylvania-works-remedy-cough-medicine-abuse\/\" target=\"_blank\" rel=\"noopener\">Coaliciones en acci\u00f3n: Pensilvania trabaja para remediar el abuso de medicamentos para la tos<\/a><\/p>\n<p><a href=\"https:\/\/www.scholastic.com\/OTCmedsafety\/\" target=\"_blank\" rel=\"noopener\">Plan de estudios de seguridad de medicamentos de venta libre<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Ayer, el Subcomit\u00e9 de Salud de Energ\u00eda y Comercio de la C\u00e1mara de Representantes aprob\u00f3 por unanimidad 12 iniciativas legislativas bipartidistas destinadas a abordar la lucha contra los opioides y las drogas.<\/p>","protected":false},"author":23,"featured_media":0,"template":"","resource_type":[281],"drug_specific_issues":[312,307],"action_to_do":[297],"class_list":["post-17538","resource","type-resource","status-publish","hentry","resource_type-coalitions-online","drug_specific_issues-heroin","drug_specific_issues-prescription-and-over-the-counter-medications","action_to_do-advocate-for-change"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee | CADCA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cadca.org\/es\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee | CADCA\" \/>\n<meta property=\"og:description\" content=\"Yesterday, the House Energy &#038; Commerce Health Subcommittee unanimously approved 12 bi-partisan legislative initiatives aimed at tackling opioid and drug\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cadca.org\/es\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/\" \/>\n<meta property=\"og:site_name\" content=\"CADCA\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cadca-member-of-logo1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"880\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\\\/\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\\\/\",\"name\":\"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee | CADCA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\"},\"datePublished\":\"2016-04-21T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cadca.org\\\/resource\\\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cadca.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/\",\"name\":\"CADCA\",\"description\":\"The Premier Prevention Association\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cadca.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee | CADCA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cadca.org\/es\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/","og_locale":"es_ES","og_type":"article","og_title":"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee | CADCA","og_description":"Yesterday, the House Energy &#038; Commerce Health Subcommittee unanimously approved 12 bi-partisan legislative initiatives aimed at tackling opioid and drug","og_url":"https:\/\/www.cadca.org\/es\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/","og_site_name":"CADCA","og_image":[{"width":880,"height":500,"url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cadca-member-of-logo1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cadca.org\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/","url":"https:\/\/www.cadca.org\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/","name":"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee | CADCA","isPartOf":{"@id":"https:\/\/www.cadca.org\/#website"},"datePublished":"2016-04-21T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.cadca.org\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cadca.org\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cadca.org\/resource\/critical-substance-abuse-legislation-passes-the-house-energy-and-commerce-health-subcommittee\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cadca.org\/"},{"@type":"ListItem","position":2,"name":"Critical Substance Abuse Legislation Passes the House Energy and Commerce Health Subcommittee"}]},{"@type":"WebSite","@id":"https:\/\/www.cadca.org\/#website","url":"https:\/\/www.cadca.org\/","name":"CADCA","description":"The Premier Prevention Association","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cadca.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/resource\/17538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/types\/resource"}],"author":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/users\/23"}],"version-history":[{"count":0,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/resource\/17538\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/media?parent=17538"}],"wp:term":[{"taxonomy":"resource_type","embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/resource_type?post=17538"},{"taxonomy":"drug_specific_issues","embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/drug_specific_issues?post=17538"},{"taxonomy":"action_to_do","embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/action_to_do?post=17538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}